Abstracts 

 Do you have a project that you recently completed? Or an antibody that required a creative approach to identify? What about the data that is due next week for the Medical Director? You have the beginnings of an abstract!
The SCABB Annual Meeting & AIMS is a great opportunity to present original investigations. Having an abstract accepted at the Annual Meeting is not only an honor but can serve as a nice entry into a CV. There is no limit to the number of abstracts an individual can submit, and it is a great experience to present an oral or poster presentation. Abstracts are welcome from SCABB Members and non-members and are printed into the Abstract Journal for the year accepted.

Abstract Guidelines:

Abstracts may be from any discipline relating to hospitals, donor centers, cellular therapy, or testing laboratories.

Abstracts should be presented for presentation in one of the following formats:

  • Oral - 10 minute oral presentation by an author, plus 5 minutes for Q&A
  • Poster - For the 2026 meeting, posters will be displayed in a digital format in lieu of traditional posters*. To ensure your poster is displayed correctly, please ensure all poster submissions meet the following format requirements:
    • Landscape orientation (16:9 aspect ratio)
    • Recommended size: 1920x1080 pixels
    • File Format: PDF preferred
    • Text and graphics should be designed for viewing from several feet away.

*Digital format subject to change regarding digital display cost and availability.

Abstracts must be submitted electronically reflecting original investiation in the specified format as designated by Objective Methods Results and Conclusion. See Abstract Guidelines.

All abstracts are peer reviewed by a panel of committee members to judge the scientific merit of each submission. There is no guarantee of acceptance, but there is a reasonably high acceptance rate of appropriately structured submissions if entered prior to the deadline.

Submit your Abstract Here

Abstracts must be submitted by Friday, February 15, 2026 to be considered.

 

Abstract Resources